Imovax

Imovax

a trademark for a rabies virus vaccine (rabies human diploid cell vaccine).
References in periodicals archive ?
Sanofi Pasteur and Chumakov Institute Russian Academy Medical Sciences Providers of Inactivated Polio Vaccine (IPV) IMOVAX PolioTM for Russia National "Project Health"
Four-million doses of IPV IMOVAX PolioTM have been delivered to date, ensuring that a complete birth cohort (approximately 1.
Later that month, however, Sanofi Pasteur, in coordination with the CDC, resumed shipping Imovax rabies vaccine for post-exposure prophylaxis only.
began a planned renovation of its Imovax Rabies vaccine production facility in France to maintain compliance with both FDA and French regulatory requirements.